Evidence map›Paper›PMID 42060148›Full record

ArticleTargeted oncology2026

Consideration of Enrollment Rates of Asian, Asian Pacific Islander, and Hispanic Patients in Non-small Cell Lung Cancer Trials.

Vinay Nittur, Cathleen J Park, Misako Nagasaka

Abstract readEditorial
In one paragraph

Article in Targeted oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vinay NitturUniversity of California Irvine School of Medicine, 101 The City Drive, Orange, CA, 92868, USA.
Cathleen J ParkUniversity of California Irvine School of Medicine, 101 The City Drive, Orange, CA, 92868, USA.
Misako NagasakaUniversity of California Irvine School of Medicine, 101 The City Drive, Orange, CA, 92868, USA. nagasakm@hs.uci.edu.ORCID http://orcid.org/0000-0001-5308-615X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite efforts over the last decade by clinical investigators and organizations to enhance diversity in clinical trials, significant underrepresentation of Asian, Asian Pacific Islander, and Hispanic patients remains an issue. Our editorial highlights key barriers to achieving equity in clinical trial enrollment among patients with non-small cell lung cancer (NSCLC) along with strategies to improve diversity to ensure more generalized clinical outcomes.

Indexed as

Carcinoma, Non-Small-Cell LungClinical Trials as TopicLung NeoplasmsPatient SelectionHispanic or LatinoHumansNative Hawaiian or Pacific Islander

Identifiers

PMID42060148
PMCPMC13222257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.